China's Gene-Editing Tragedy: A Wake-Up Call for Regulation
The death of a six-year-old girl in China, following an experimental gene-editing treatment, underscores the urgent need for regulatory frameworks in biotechnology. As China accelerates its gene-editing trials, this incident raises ethical concerns and transparency issues, revealing the human cost …
Read more →
